Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations

RW Holloway, NR Abu-Rustum, FJ Backes… - Gynecologic …, 2017 - Elsevier
The emphasis in contemporary medical oncology has been “precision” or “personalized”
medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar …

Vulvar cancer: epidemiology, clinical presentation, and management options

I Alkatout, M Schubert, N Garbrecht… - … journal of women's …, 2015 - Taylor & Francis
Epidemiology Vulvar cancer can be classified into two groups according to predisposing
factors: the first type correlates with a HPV infection and occurs mostly in younger patients …

Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II

MHM Oonk, B Slomovitz, PJW Baldwin… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE The Groningen International Study on Sentinel nodes in Vulvar cancer
(GROINSS-V)-II investigated whether inguinofemoral radiotherapy is a safe alternative to …

Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)

M Ballester, G Dubernard, F Lécuru, D Heitz… - The lancet …, 2011 - thelancet.com
Background Retrospective single-centre series have shown the feasibility of sentinel lymph-
node (SLN) identification in endometrial cancer. We did a prospective, multicentre cohort …

Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I

NC te Grootenhuis, AGJ Van Der Zee… - Gynecologic …, 2016 - Elsevier
Abstract Objective In 2008 GROINSS-VI, the largest validation trial on the sentinel node (SN)
procedure in vulvar cancer, showed that application of the SN-procedure in patients with …

Vulvar cancer

D Weinberg… - Obstetrics and Gynecology …, 2019 - obgyn.theclinics.com
There will be an estimated 6190 new cases of vulvar cancer in 2018, accounting for 0.4% of
all cancers. This is primarily a disease of the elderly with a median age at diagnosis of 68 …

Vulvar cancer, version 1.2017, NCCN clinical practice guidelines in oncology

WJ Koh, BE Greer, NR Abu-Rustum… - Journal of the National …, 2017 - jnccn.org
Vulvar cancer is a rare gynecologic malignancy. Ninety percent of vulvar cancers are
predominantly squamous cell carcinomas (SCCs), which can arise through human …

Adjuvant therapy in lymph node–positive vulvar cancer: the AGO-CaRE-1 study

S Mahner, J Jueckstock, F Hilpert… - Journal of the …, 2015 - academic.oup.com
Background: Women with node-positive vulvar cancer have a high risk for disease
recurrence. Indication criteria for adjuvant radiotherapy are controversial. This study was …

[HTML][HTML] Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes

KE Kortekaas, E Bastiaannet, HC van Doorn… - Gynecologic …, 2020 - Elsevier
Objective There is great need for better risk stratification in vulvar squamous cell carcinoma
(VSCC). Our aim was to define the prognostic significance of stratifying VSCC based on p16 …

Lower extremity lymphedema in patients with gynecologic malignancies

K Dessources, E Aviki, MM Leitao Jr - International Journal of …, 2020 - ijgc.bmj.com
Lower extremity lymphedema is a chronic, often irreversible condition that affects many
patients treated for gynecologic malignancies, with published rates as high as 70% in select …